EdgarLookup

NIKA PHARMACEUTICALS, INC

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to NIKA PHARMACEUTICALS, INC. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

NIKA
Company Title Type Shares Price Value Date
NIKA President, CEO, CFO Sale 6,300,000 $0.01 $63,000 Sep 12, 2022
NIKA Secretary Other 5,000,000 $50,000.00 $250,000,000,000 Jul 20, 2022